Structure

Physi-Chem Properties

Molecular Weight:  582.17
Volume:  572.975
LogP:  4.047
LogD:  2.478
LogS:  -3.908
# Rotatable Bonds:  14
TPSA:  186.12
# H-Bond Aceptor:  12
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.151
Synthetic Accessibility Score:  3.743
Fsp3:  0.267
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.218
MDCK Permeability:  2.7265361495665275e-05
Pgp-inhibitor:  0.989
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.012
30% Bioavailability (F30%):  0.007

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.007
Plasma Protein Binding (PPB):  99.54859161376953%
Volume Distribution (VD):  0.32
Pgp-substrate:  1.39404296875%

ADMET: Metabolism

CYP1A2-inhibitor:  0.696
CYP1A2-substrate:  0.011
CYP2C19-inhibitor:  0.723
CYP2C19-substrate:  0.046
CYP2C9-inhibitor:  0.885
CYP2C9-substrate:  0.942
CYP2D6-inhibitor:  0.017
CYP2D6-substrate:  0.125
CYP3A4-inhibitor:  0.195
CYP3A4-substrate:  0.191

ADMET: Excretion

Clearance (CL):  1.257
Half-life (T1/2):  0.914

ADMET: Toxicity

hERG Blockers:  0.0
Human Hepatotoxicity (H-HT):  0.064
Drug-inuced Liver Injury (DILI):  0.964
AMES Toxicity:  0.038
Rat Oral Acute Toxicity:  0.351
Maximum Recommended Daily Dose:  0.053
Skin Sensitization:  0.258
Carcinogencity:  0.588
Eye Corrosion:  0.003
Eye Irritation:  0.448
Respiratory Toxicity:  0.029

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC7178

Natural Product ID:  NPC7178
Common Name*:   Curtisian M
IUPAC Name:   [4-[(3R)-3-acetyloxybutanoyl]oxy-2,5-dihydroxy-3,6-bis(4-hydroxyphenyl)phenyl] (3R)-3-acetyloxybutanoate
Synonyms:   Curtisian M
Standard InCHIKey:  ZSTKODOFTJPOLN-HZPDHXFCSA-N
Standard InCHI:  InChI=1S/C30H30O12/c1-15(39-17(3)31)13-23(35)41-29-25(19-5-9-21(33)10-6-19)28(38)30(42-24(36)14-16(2)40-18(4)32)26(27(29)37)20-7-11-22(34)12-8-20/h5-12,15-16,33-34,37-38H,13-14H2,1-4H3/t15-,16-/m1/s1
SMILES:  C[C@H](CC(=O)Oc1c(c2ccc(cc2)O)c(c(c(c2ccc(cc2)O)c1O)OC(=O)C[C@@H](C)OC(=O)C)O)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL558743
PubChem CID:   45267452
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0002042] Terphenyls
          • [CHEMONTID:0002126] P-terphenyls

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16348 Paxillus curtisii Species Paxillaceae Eukaryota n.a. fruit body n.a. PMID[10805570]
NPO16348 Paxillus curtisii Species Paxillaceae Eukaryota fruiting bodies Odae National Parks, Korea n.a. PMID[19450986]
NPO16348 Paxillus curtisii Species Paxillaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16348 Paxillus curtisii Species Paxillaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1 Others Radical scavenging activity IC50 > 500000.0 nM PMID[521210]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 8150.0 nM PMID[521210]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 500000.0 nM PMID[521210]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC7178 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC62903
0.9932 High Similarity NPC142479
0.9932 High Similarity NPC155015
0.9796 High Similarity NPC476154
0.9658 High Similarity NPC113790
0.9542 High Similarity NPC55121
0.9542 High Similarity NPC174311
0.9521 High Similarity NPC97937
0.9521 High Similarity NPC275125
0.9521 High Similarity NPC170239
0.9384 High Similarity NPC125617
0.929 High Similarity NPC476200
0.929 High Similarity NPC192258
0.9276 High Similarity NPC292385
0.9276 High Similarity NPC125709
0.9241 High Similarity NPC476279
0.915 High Similarity NPC476642
0.9032 High Similarity NPC36077
0.8974 High Similarity NPC36354
0.8954 High Similarity NPC163598
0.8954 High Similarity NPC120774
0.8954 High Similarity NPC264875
0.8904 High Similarity NPC25111
0.8904 High Similarity NPC90615
0.8904 High Similarity NPC73535
0.8904 High Similarity NPC272157
0.8904 High Similarity NPC201145
0.8904 High Similarity NPC6262
0.8896 High Similarity NPC78809
0.8882 High Similarity NPC30688
0.8882 High Similarity NPC176903
0.8874 High Similarity NPC208507
0.8874 High Similarity NPC472333
0.8859 High Similarity NPC256555
0.8859 High Similarity NPC91492
0.8859 High Similarity NPC7439
0.8859 High Similarity NPC110067
0.8859 High Similarity NPC34245
0.8844 High Similarity NPC22517
0.8836 High Similarity NPC300846
0.8836 High Similarity NPC476639
0.8836 High Similarity NPC114155
0.8827 High Similarity NPC265214
0.8824 High Similarity NPC294522
0.8824 High Similarity NPC21184
0.8824 High Similarity NPC120426
0.8824 High Similarity NPC205727
0.8808 High Similarity NPC268515
0.8808 High Similarity NPC40222
0.8792 High Similarity NPC469564
0.8784 High Similarity NPC165026
0.8784 High Similarity NPC73505
0.8784 High Similarity NPC295719
0.8784 High Similarity NPC34431
0.8776 High Similarity NPC102904
0.8776 High Similarity NPC326797
0.8776 High Similarity NPC176051
0.8776 High Similarity NPC103976
0.8776 High Similarity NPC474282
0.8776 High Similarity NPC107551
0.8767 High Similarity NPC283009
0.8767 High Similarity NPC111655
0.8767 High Similarity NPC261873
0.8765 High Similarity NPC67424
0.8742 High Similarity NPC155754
0.8742 High Similarity NPC109061
0.8742 High Similarity NPC124747
0.8733 High Similarity NPC477616
0.8726 High Similarity NPC165483
0.8725 High Similarity NPC471389
0.8718 High Similarity NPC8712
0.8716 High Similarity NPC245207
0.8716 High Similarity NPC127218
0.8716 High Similarity NPC319647
0.8716 High Similarity NPC25966
0.8707 High Similarity NPC472336
0.8707 High Similarity NPC472334
0.8704 High Similarity NPC167231
0.8704 High Similarity NPC215802
0.8699 High Similarity NPC103967
0.8693 High Similarity NPC175976
0.8693 High Similarity NPC187398
0.8693 High Similarity NPC139839
0.8693 High Similarity NPC476348
0.8693 High Similarity NPC477879
0.8679 High Similarity NPC301089
0.8675 High Similarity NPC87883
0.8667 High Similarity NPC472332
0.8667 High Similarity NPC107161
0.8667 High Similarity NPC175838
0.8667 High Similarity NPC472335
0.8658 High Similarity NPC291101
0.8658 High Similarity NPC22317
0.8658 High Similarity NPC254759
0.8658 High Similarity NPC160283
0.8658 High Similarity NPC266197
0.8654 High Similarity NPC475141
0.8654 High Similarity NPC149735
0.8654 High Similarity NPC473236
0.8649 High Similarity NPC276490
0.8639 High Similarity NPC474206
0.8639 High Similarity NPC252095
0.8639 High Similarity NPC94750
0.8639 High Similarity NPC470356
0.8639 High Similarity NPC112939
0.8639 High Similarity NPC112246
0.8639 High Similarity NPC472337
0.8639 High Similarity NPC121812
0.8639 High Similarity NPC224941
0.8639 High Similarity NPC311430
0.8627 High Similarity NPC476347
0.8627 High Similarity NPC15577
0.8627 High Similarity NPC178129
0.8616 High Similarity NPC98083
0.8616 High Similarity NPC24339
0.8616 High Similarity NPC94220
0.8616 High Similarity NPC166456
0.8616 High Similarity NPC7543
0.86 High Similarity NPC247291
0.86 High Similarity NPC311530
0.86 High Similarity NPC178054
0.8599 High Similarity NPC268484
0.8599 High Similarity NPC473736
0.8598 High Similarity NPC91043
0.8591 High Similarity NPC471388
0.8591 High Similarity NPC29868
0.8591 High Similarity NPC212942
0.8591 High Similarity NPC292882
0.8591 High Similarity NPC79622
0.859 High Similarity NPC476434
0.8581 High Similarity NPC227503
0.8581 High Similarity NPC265433
0.8581 High Similarity NPC471719
0.8581 High Similarity NPC16435
0.8581 High Similarity NPC306441
0.8581 High Similarity NPC162659
0.8581 High Similarity NPC230734
0.8581 High Similarity NPC474639
0.8581 High Similarity NPC173660
0.8581 High Similarity NPC270456
0.8581 High Similarity NPC248727
0.858 High Similarity NPC142614
0.8571 High Similarity NPC252402
0.8571 High Similarity NPC281549
0.8571 High Similarity NPC48366
0.8571 High Similarity NPC474600
0.8571 High Similarity NPC310854
0.8571 High Similarity NPC106215
0.8571 High Similarity NPC102934
0.8563 High Similarity NPC297807
0.8562 High Similarity NPC190714
0.8562 High Similarity NPC218884
0.8562 High Similarity NPC474054
0.8562 High Similarity NPC475896
0.8562 High Similarity NPC99515
0.8562 High Similarity NPC317053
0.8562 High Similarity NPC260397
0.8562 High Similarity NPC112251
0.8562 High Similarity NPC324492
0.8562 High Similarity NPC53889
0.8553 High Similarity NPC45257
0.8553 High Similarity NPC50250
0.8553 High Similarity NPC93323
0.8553 High Similarity NPC280092
0.8553 High Similarity NPC12641
0.8553 High Similarity NPC125495
0.8545 High Similarity NPC158226
0.8543 High Similarity NPC131971
0.8535 High Similarity NPC150442
0.8535 High Similarity NPC474656
0.8535 High Similarity NPC199773
0.8535 High Similarity NPC65591
0.8535 High Similarity NPC178574
0.8535 High Similarity NPC289968
0.8535 High Similarity NPC223720
0.8533 High Similarity NPC259519
0.8533 High Similarity NPC308768
0.8533 High Similarity NPC12668
0.8533 High Similarity NPC27495
0.8533 High Similarity NPC309124
0.8533 High Similarity NPC184797
0.8526 High Similarity NPC225129
0.8523 High Similarity NPC38874
0.8523 High Similarity NPC474886
0.8523 High Similarity NPC476171
0.8523 High Similarity NPC211549
0.8523 High Similarity NPC105493
0.8523 High Similarity NPC48956
0.8516 High Similarity NPC475250
0.8516 High Similarity NPC125570
0.8516 High Similarity NPC474393
0.8516 High Similarity NPC474347
0.8514 High Similarity NPC47398
0.8514 High Similarity NPC201357
0.8514 High Similarity NPC234333
0.8514 High Similarity NPC61946
0.8514 High Similarity NPC151224
0.8514 High Similarity NPC255147
0.8514 High Similarity NPC281521
0.8514 High Similarity NPC195022

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC7178 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8537 High Similarity NPD5844 Phase 1
0.8375 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6232 Discontinued
0.8311 Intermediate Similarity NPD1613 Approved
0.8311 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD1934 Approved
0.828 Intermediate Similarity NPD1653 Approved
0.8272 Intermediate Similarity NPD6234 Discontinued
0.825 Intermediate Similarity NPD2801 Approved
0.8242 Intermediate Similarity NPD6166 Phase 2
0.8242 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8231 Intermediate Similarity NPD3027 Phase 3
0.8193 Intermediate Similarity NPD7473 Discontinued
0.8163 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD3817 Phase 2
0.8075 Intermediate Similarity NPD37 Approved
0.8061 Intermediate Similarity NPD7199 Phase 2
0.8037 Intermediate Similarity NPD4967 Phase 2
0.8037 Intermediate Similarity NPD4966 Approved
0.8037 Intermediate Similarity NPD4965 Approved
0.8012 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7943 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7941 Intermediate Similarity NPD7074 Phase 3
0.7929 Intermediate Similarity NPD3818 Discontinued
0.7929 Intermediate Similarity NPD7228 Approved
0.7919 Intermediate Similarity NPD4908 Phase 1
0.7914 Intermediate Similarity NPD1465 Phase 2
0.7882 Intermediate Similarity NPD7054 Approved
0.7849 Intermediate Similarity NPD6559 Discontinued
0.7836 Intermediate Similarity NPD7472 Approved
0.7818 Intermediate Similarity NPD3882 Suspended
0.7815 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD1511 Approved
0.7791 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7075 Discontinued
0.7763 Intermediate Similarity NPD6233 Phase 2
0.7758 Intermediate Similarity NPD5402 Approved
0.775 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD6959 Discontinued
0.7711 Intermediate Similarity NPD7768 Phase 2
0.7702 Intermediate Similarity NPD1512 Approved
0.7702 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7701 Intermediate Similarity NPD7549 Discontinued
0.7697 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD6798 Discontinued
0.7688 Intermediate Similarity NPD6797 Phase 2
0.7679 Intermediate Similarity NPD5494 Approved
0.7644 Intermediate Similarity NPD7251 Discontinued
0.7632 Intermediate Similarity NPD4625 Phase 3
0.7622 Intermediate Similarity NPD6599 Discontinued
0.7616 Intermediate Similarity NPD2861 Phase 2
0.76 Intermediate Similarity NPD7808 Phase 3
0.7597 Intermediate Similarity NPD4060 Phase 1
0.759 Intermediate Similarity NPD7819 Suspended
0.759 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD7411 Suspended
0.7568 Intermediate Similarity NPD1610 Phase 2
0.7562 Intermediate Similarity NPD6190 Approved
0.756 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD6801 Discontinued
0.7516 Intermediate Similarity NPD7095 Approved
0.7515 Intermediate Similarity NPD4380 Phase 2
0.75 Intermediate Similarity NPD4628 Phase 3
0.75 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD3787 Discontinued
0.7485 Intermediate Similarity NPD8455 Phase 2
0.7472 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD6799 Approved
0.7468 Intermediate Similarity NPD1551 Phase 2
0.7468 Intermediate Similarity NPD2935 Discontinued
0.7467 Intermediate Similarity NPD4749 Approved
0.745 Intermediate Similarity NPD422 Phase 1
0.7443 Intermediate Similarity NPD7240 Approved
0.7439 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD5403 Approved
0.7438 Intermediate Similarity NPD1652 Phase 2
0.7438 Intermediate Similarity NPD6674 Discontinued
0.7436 Intermediate Similarity NPD6355 Discontinued
0.7427 Intermediate Similarity NPD8127 Discontinued
0.7423 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD7266 Discontinued
0.7415 Intermediate Similarity NPD1548 Phase 1
0.7405 Intermediate Similarity NPD7033 Discontinued
0.7391 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD3750 Approved
0.7391 Intermediate Similarity NPD4110 Phase 3
0.7386 Intermediate Similarity NPD3018 Phase 2
0.7384 Intermediate Similarity NPD7229 Phase 3
0.7375 Intermediate Similarity NPD1549 Phase 2
0.7368 Intermediate Similarity NPD6746 Phase 2
0.7358 Intermediate Similarity NPD6099 Approved
0.7358 Intermediate Similarity NPD6100 Approved
0.7355 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD3749 Approved
0.7351 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD3226 Approved
0.7333 Intermediate Similarity NPD1611 Approved
0.7329 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD5124 Phase 1
0.7325 Intermediate Similarity NPD447 Suspended
0.7317 Intermediate Similarity NPD2534 Approved
0.7317 Intermediate Similarity NPD2533 Approved
0.7317 Intermediate Similarity NPD5401 Approved
0.7317 Intermediate Similarity NPD2532 Approved
0.7317 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD3751 Discontinued
0.731 Intermediate Similarity NPD919 Approved
0.7273 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD8312 Approved
0.7263 Intermediate Similarity NPD8313 Approved
0.7262 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD2797 Approved
0.725 Intermediate Similarity NPD2796 Approved
0.7246 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD3926 Phase 2
0.7237 Intermediate Similarity NPD2982 Phase 2
0.7237 Intermediate Similarity NPD2983 Phase 2
0.7233 Intermediate Similarity NPD7097 Phase 1
0.7222 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD230 Phase 1
0.7205 Intermediate Similarity NPD5762 Approved
0.7205 Intermediate Similarity NPD5763 Approved
0.72 Intermediate Similarity NPD1778 Approved
0.7188 Intermediate Similarity NPD1510 Phase 2
0.7171 Intermediate Similarity NPD2981 Phase 2
0.717 Intermediate Similarity NPD1607 Approved
0.7165 Intermediate Similarity NPD7783 Phase 2
0.7165 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD7680 Approved
0.7152 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3496 Discontinued
0.7152 Intermediate Similarity NPD4140 Approved
0.7152 Intermediate Similarity NPD3620 Phase 2
0.7151 Intermediate Similarity NPD7038 Approved
0.7151 Intermediate Similarity NPD7039 Approved
0.7143 Intermediate Similarity NPD6032 Approved
0.7143 Intermediate Similarity NPD2438 Suspended
0.7134 Intermediate Similarity NPD3268 Approved
0.7128 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD1247 Approved
0.7123 Intermediate Similarity NPD5535 Approved
0.7108 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD3686 Approved
0.7083 Intermediate Similarity NPD3687 Approved
0.7081 Intermediate Similarity NPD3748 Approved
0.7078 Intermediate Similarity NPD3225 Approved
0.7075 Intermediate Similarity NPD5283 Phase 1
0.7063 Intermediate Similarity NPD6653 Approved
0.7059 Intermediate Similarity NPD1608 Approved
0.7055 Intermediate Similarity NPD228 Approved
0.7048 Intermediate Similarity NPD7212 Phase 2
0.7048 Intermediate Similarity NPD7213 Phase 3
0.7044 Intermediate Similarity NPD1240 Approved
0.7041 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD7985 Registered
0.7006 Intermediate Similarity NPD7446 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7447 Phase 1
0.7006 Intermediate Similarity NPD6832 Phase 2
0.7 Intermediate Similarity NPD1933 Approved
0.6994 Remote Similarity NPD2346 Discontinued
0.6994 Remote Similarity NPD6800 Clinical (unspecified phase)
0.6993 Remote Similarity NPD1535 Discovery
0.6993 Remote Similarity NPD1091 Approved
0.6987 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6981 Remote Similarity NPD4062 Phase 3
0.698 Remote Similarity NPD6671 Approved
0.6975 Remote Similarity NPD4308 Phase 3
0.6974 Remote Similarity NPD4626 Approved
0.6974 Remote Similarity NPD8151 Discontinued
0.6971 Remote Similarity NPD4666 Phase 3
0.697 Remote Similarity NPD8166 Discontinued
0.6968 Remote Similarity NPD1283 Approved
0.6964 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7685 Pre-registration
0.6957 Remote Similarity NPD8434 Phase 2
0.6954 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6948 Remote Similarity NPD1481 Phase 2
0.6946 Remote Similarity NPD4357 Discontinued
0.6946 Remote Similarity NPD7390 Discontinued
0.694 Remote Similarity NPD8054 Approved
0.694 Remote Similarity NPD8053 Approved
0.6937 Remote Similarity NPD943 Approved
0.6937 Remote Similarity NPD1558 Phase 1
0.6937 Remote Similarity NPD2979 Phase 3
0.6933 Remote Similarity NPD5408 Approved
0.6933 Remote Similarity NPD5405 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data